SCHEMBL551716

SCHEMBL551716

CCCCOC(=O)c1cccnc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 1.00
LMNA P02545 7/20 0.89
KMT2A Q03164 6/20 0.76
MAPT P10636 3/20 0.76
ALDH1A1 P00352 3/20 0.76
MEN1 O00255 1/20 0.76
HPGD P15428 1/20 0.76
TSHR P16473 4/20 0.70
CYP1A2 P05177 3/20 0.70
CYP2C19 P33261 3/20 0.70
CYP2C9 P11712 2/20 0.70
NFKB1 P19838 2/20 0.65
NFKB2 Q00653 2/20 0.65
RELA Q04206 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
NPC1 O15118 1/20 0.65
POLB P06746 1/20 0.65
TDP1 Q9NUW8 2/20 0.57
ESR1 P03372 1/20 0.55
CYP2D6 P10635 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5559952 0.98 L3MBTL1 (0.97) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL551811 0.95 LMNA (0.97) L3MBTL1LMNAKMT2AMAPTALDH1A1
Sulfuric Acid SCHEMBL11419955 0.94 L3MBTL1 (0.89) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL135491 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL10460555 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL589021 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL285214 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL22092312 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL9717064 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1
SCHEMBL4275232 0.94 LMNA (1.00) L3MBTL1LMNAKMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994269-A Preparation method of beta-nicotinamide mononucleotide 上海昶法新材料有限公司 2024-11-22 CN claimed
CN-116444581-A Beta-nicotinamide mononucleotide and preparation method thereof 上海昶法新材料有限公司 2023-07-18 CN claimed
CN-113527376-A Preparation method of beta-nicotinamide mononucleotide 上海昶法新材料有限公司 2021-10-22 CN claimed
CN-111253448-B Preparation method and purification method of beta-nicotinamide mononucleotide 上海昶法新材料有限公司 2021-09-21 CN claimed
WO-2021127986-A1 NICOTINE PREPARATION METHOD 深圳雾芯科技有限公司 2021-07-01 WO claimed
CN-111253448-A Preparation method and purification method of β -nicotinamide mononucleotide 上海昶法新材料有限公司 2020-06-09 CN claimed
CN-111004212-A Method for preparing nicotine 深圳雾芯科技有限公司 2020-04-14 CN claimed
WO-2008083034-A1 TRANSDERMAL VITAMIN B12 DELIVERY PATCH NEXAGEN USA, LLC (US) 2008-07-10 WO claimed
US-20080160070-A1 TRANSDERMAL VITAMIN B12 DELIVERY PATCH NEXAGEN USA LLC (US) 2008-07-03 US claimed
CN-1301991-C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same STC NARA CO LTD (KR) 2007-02-28 CN claimed
EP-1633334-B1 TOPICAL ADMINISTRATION OF VASOACTIVE VITAMIN B3 COMPOUNDS FOR PROMOTING SLEEP PROCTER & GAMBLE (US) 2006-11-15 EP claimed
EP-1633334-A2 A METHOD OF PROMOTING SLEEP USING TOPICAL ADMINISTRATION OF VASOACTIVE AGENTS THE PROCTER & GAMBLE COMPANY (US) 2006-03-15 EP claimed
CN-1571784-A Piperidine derivatives, process for preparing the same, and pharmaceutical composition for treating alzheimer's disease containing the same STC NARA CO LTD (KR) 2005-01-26 CN claimed
WO-2005002554-A2 A METHOD OF PROMOTING SLEEP USING TOPICAL ADMINISTRATION OF VASOACTIVE AGENTS THE PROCTER & GAMBLE COMPANY (US) 2005-01-13 WO claimed
US-20040254202-A1 Method of promoting sleep using topical administration of vasoactive agents THE PROCTER & GAMBLE COMPANY 2004-12-16 US claimed
WO-2001019185-A2 METHODS FOR CONTROLLING A PEST POPULATION SUMMUS GROUP, LTD. (US) 2001-03-22 WO claimed
US-5939568-A Accelerated catalysis of olefinic epoxidations THE SCRIPPS RESEARCH INSTITUTE (US) 1999-08-17 US claimed
US-5043162-A Mixture of lower alkyl nicotinate and histamine hydrochloride TRAGER SEYMOUR F (US) 1991-08-27 US claimed
US-4207150-A NON-CYANIDE ZINC ELECTROPLATING BATH CONTAINING QUATERNARY BUTYL NICOTINATE SULFATE OR SULFONATE AS BRIGHTENER AND LEVELING AGENT OXY METAL INDUSTRIES CORPORATION (US) 1980-06-10 US claimed
JP-58013607-A None JP disclosed
EP-3632435-B1 BONE REGENERATION AGENT KAO CORP (JP) 2026-04-29 EP disclosed
US-12473310-B2 Vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound KING'S COLLEGE LONDON (GB) 2025-11-18 US disclosed
EP-3322419-B1 SYNTHESES, ACTIVITIES, AND METHODS OF USE OF DIHYDRONICOTINAMIDE RIBOSIDE DERIVATIVES UNIV CORNELL (US) 2025-09-03 EP disclosed
US-20240392273-A1 FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-11-28 US disclosed
CN-118994269-A Preparation method of beta-nicotinamide mononucleotide 上海昶法新材料有限公司 2024-11-22 CN disclosed
EP-3624846-B1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY INCLUDING A COMBINATION OF NICOTINIC ACID AND TRYOPTOPHAN BHAMIS RES LABORATORY PVT LTD (IN) 2024-08-07 EP disclosed
EP-4401758-A1 FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE Takeda Pharmaceutical Company Limited (JP) 2024-07-24 EP disclosed
CN-118139636-A Delivery of promoted concentrated antibody formulations using hyaluronidase 武田药品工业株式会社 2024-06-04 CN disclosed
US-20240115702-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY Bhami's Research Laboratory, Pvt. Ltd. (IN) 2024-04-11 US disclosed
US-20240116959-A1 VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND KING'S COLLEGE LONDON (GB) 2024-04-11 US disclosed
US-11926644-B2 Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives CORNELL UNIVERSITY (US) 2024-03-12 US disclosed
CN-108137542-B Pyridone dicarboxamides as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2023-10-27 CN disclosed
EP-4232148-A1 VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND King's College London (GB) 2023-08-30 EP disclosed
US-11738082-B2 High concentration protein formulations with reduced viscosity Bhami's Research Laboratory, Pvt. Ltd. (IN) 2023-08-29 US disclosed
US-20230263718-A1 COMPOSITION FOR TREATING HAIR OR FIBERS, COMPRISING ALKYL KETENE COMPOUND LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2023-08-24 US disclosed
CN-114621185-B Synthesis method of raceme nicotine 昆山美淼新材料科技有限公司 2023-08-22 CN disclosed
US-20230242843-A1 GREEN SOLVENT, LAUNDRY COMPOSITION COMPRISING SAME, AND WASHING MACHINE LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2023-08-03 US disclosed
CN-116444581-A Beta-nicotinamide mononucleotide and preparation method thereof 上海昶法新材料有限公司 2023-07-18 CN disclosed
EP-4180509-A1 GREEN SOLVENT, LAUNDRY COMPOSITION COMPRISING SAME, AND WASHING MACHINE LG Household & Health Care Ltd. (KR) 2023-05-17 EP disclosed
WO-2023042096-A1 FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-03-23 WO disclosed
CN-115702234-A Environment-friendly solvent, and washing composition and washing device comprising same 株式会社LG生活健康 2023-02-14 CN disclosed
CN-115701977-A Composition for treating hair or fiber comprising alkylketene compound 株式会社LG生活健康 2023-02-14 CN disclosed
CN-110709406-B Beta-nicotinate nucleotide and preparation method thereof 康奈尔大学 2022-11-08 CN disclosed
CN-110678179-B Bone regeneration agent 花王株式会社 2022-10-14 CN disclosed
CN-114621185-A Synthesis method of racemate nicotine 昆山美淼新材料科技有限公司 2022-06-14 CN disclosed
WO-2022084669-A1 VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND KING'S COLLEGE LONDON (GB) 2022-04-28 WO disclosed
WO-2021261726-A1 COMPOSITION FOR TREATING HAIR OR FIBERS, COMPRISING ALKYL KETENE COMPOUND 주식회사 엘지생활건강 2021-12-30 WO disclosed
CN-113527376-A Preparation method of beta-nicotinamide mononucleotide 上海昶法新材料有限公司 2021-10-22 CN disclosed
CN-111253448-B Preparation method and purification method of beta-nicotinamide mononucleotide 上海昶法新材料有限公司 2021-09-21 CN disclosed
EP-2524958-B1 LUBRICANT COMPOSITIONS CONTAINING A HETEROAROMATIC COMPOUND AFTON CHEMICAL CORP (US) 2021-07-07 EP disclosed
WO-2021127986-A1 NICOTINE PREPARATION METHOD 深圳雾芯科技有限公司 2021-07-01 WO disclosed
CN-112673257-A Composition of surface-modified therapeutically active particles prepared by ultra-rapid freezing 德克萨斯大学系统董事会 2021-04-16 CN disclosed
US-10952960-B2 Bone regeneration agent KAO CORPORATION (JP) 2021-03-23 US disclosed
US-10759776-B2 Synthesis and resolution of nicotine NJOY, LLC (US) 2020-09-01 US disclosed
US-20200254094-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY Bhami's Research Laboratory, Pvt. Ltd. (IN) 2020-08-13 US disclosed
EP-3155901-B1 MATERIAL AND FOOD PACKAGE FOR INHIBITING DEGRADATION IN FRESHNESS OF MYOGLOBIN-CONTAINING FOOD, AND METHOD USING THE SAME SEKISUI PLASTICS (JP) 2020-06-10 EP disclosed
CN-111253448-A Preparation method and purification method of β -nicotinamide mononucleotide 上海昶法新材料有限公司 2020-06-09 CN disclosed
US-10646569-B2 High concentration protein formulations with reduced viscosity Bhami's Research Laboratory, Pvt. Ltd. (IN) 2020-05-12 US disclosed
CN-111004212-A Method for preparing nicotine 深圳雾芯科技有限公司 2020-04-14 CN disclosed
EP-3632435-A1 BONE REGENERATION AGENT Kao Corporation (JP) 2020-04-08 EP disclosed
EP-3624846-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY Bhami's Research Laboratory, Pvt. Ltd. (IN) 2020-03-25 EP disclosed
US-20200087338-A1 NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS SPRING BANK PHARMACEUTICALS INC (US) 2020-03-19 US disclosed
CN-110678179-A Bone regeneration agent 花王株式会社 2020-01-10 CN disclosed
US-20190263777-A1 SYNTHESIS AND RESOLUTION OF NICOTINE NJOY, LLC (US) 2019-08-29 US disclosed
US-10329271-B2 Synthesis and resolution of nicotine NJOY, LLC (US) 2019-06-25 US disclosed
US-10308727-B2 Myoglobin-containing food freshness deterioration suppressing material and use thereof SEKISUI PLASTICS CO., LTD. (JP) 2019-06-04 US disclosed
CN-109705120-A Imidazole simultaneously [1,2-a] pyridine compounds and its preparation method and application 广东药科大学 2019-05-03 CN disclosed
WO-2018211517-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY Bhami's Research Laboratory, Pvt. Ltd. (IN) 2018-11-22 WO disclosed
US-20180333493-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY Bhami's Research Laboratory, Pvt. Ltd. (IN) 2018-11-22 US disclosed
US-20180030028-A1 SYNTHESIS AND RESOLUTION OF NICOTINE NJOY, LLC (US) 2018-02-01 US disclosed
US-9809567-B2 Synthesis and resolution of nicotine NJOY, LLC (US) 2017-11-07 US disclosed
US-20170190804-A1 MYOGLOBIN-CONTAINING FOOD FRESHNESS DETERIORATION SUPPRESSING MATERIAL AND USE THEREOF SEKISUI PLASTICS CO., LTD. (JP) 2017-07-06 US disclosed
EP-3155901-A1 MATERIAL FOR INHIBITING DEGRADATION IN FRESHNESS OF MYOGLOBIN-CONTAINING FOOD, AND USE OF SAME Sekisui Plastics Co., Ltd. (JP) 2017-04-19 EP disclosed
CN-103664973-B Spiro-oxindole compounds and their use as therapeutic agents 泽农医药公司 2017-04-19 CN disclosed
EP-2947092-B1 PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULPHONATE STEROID DERIVATIVES OLON SPA (IT) 2016-12-14 EP disclosed
US-20160326134-A1 SYNTHESIS AND RESOLUTION OF NICOTINE NJOY, INC. (US) 2016-11-10 US disclosed
EP-3008073-A1 THIENO[2,3-b]PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-04-20 EP disclosed
US-9315541-B2 Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives OLON S.P.A. (IT) 2016-04-19 US disclosed
US-20150337007-A1 PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULFONATE STEROID DERIVATIVES OLON S.P.A. (IT) 2015-11-26 US disclosed
EP-2947092-A1 PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULPHONATE STEROID DERIVATIVES OLON S.p.A. (IT) 2015-11-25 EP disclosed
US-9090847-B2 Lubricant compositions containing a heteroaromatic compound AFTON CHEMICAL CORPORATION (US) 2015-07-28 US disclosed
WO-2014199195-A1 THIENO[2,3-b]PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2014-12-18 WO disclosed
US-8822724-B2 Method for producing carboxylic acid amide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-09-02 US disclosed
US-8802204-B2 Packaging inserts with myoglobin blooming agents, packages and methods of packaging CURWOOD, INC. (US) 2014-08-12 US disclosed
US-20140199539-A1 COMPOSITE PLATED FILM AND LAMINATED FILM KOYO ENGINEERING CO., LTD. (JP) 2014-07-17 US disclosed
US-8741402-B2 Webs with synergists that promote or preserve the desirable color of meat CURWOOD, INC. (US) 2014-06-03 US disclosed
US-8673456-B2 Composite plated film and laminated film MEISEI INDUSTRIAL COMPANY LIMITED (JP) 2014-03-18 US disclosed
US-8623479-B2 Packaging articles, films and methods that promote or preserve the desirable color of meat CURWOOD, INC. (US) 2014-01-07 US disclosed
US-20130266755-A1 Packaging Inserts With Myoglobin Blooming Agents, Packages and Methods of Packaging CURWOOD, INC. (US) 2013-10-10 US disclosed
US-8545950-B2 Method for distributing a myoglobin-containing food product CURWOOD, INC. (US) 2013-10-01 US disclosed
US-8530012-B2 Packaging articles, films and methods that promote or preserve the desirable color of meat CURWOOD, INC. (US) 2013-09-10 US disclosed
US-8470417-B2 Packaging inserts with myoglobin blooming agents, packages and methods for packaging CURWOOD, INC. (US) 2013-06-25 US disclosed
EP-2599769-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE Sumitomo Chemical Company Limited (JP) 2013-06-05 EP disclosed
US-20130123505-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE SUMITOMO CHEMICAL COMPANY, LIMITED 2013-05-16 US disclosed
US-20130022687-A1 TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING FITZGERALD JR JOHN JAMES (US) 2013-01-24 US disclosed
US-20120291737-A1 LUBRICANT COMPOSITIONS CONTAINING A HETEROAROMATIC COMPOUND AFTON CHEMICAL CORPORATION (US) 2012-11-22 US disclosed
EP-2524958-A1 Lubricant compositions containing a heteroaromatic compound Afton Chemical Corporation (US) 2012-11-21 EP disclosed
US-20120270900-A1 NOVEL METHOD OF TREATMENT TOPO TARGET A/S (DK) 2012-10-25 US disclosed
US-20120264709-A1 NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS SPRING BANK PHARMACEUTICALS, INC. (US) 2012-10-18 US disclosed
US-20120107466-A1 Packaging Articles, Films and Methods That Promote or Preserve The Desirable Color of Meat CURWOOD, INC. (US) 2012-05-03 US disclosed
US-20120100267-A1 Packaging Articles, Films and Methods That Promote or Preserve the Desirable Color of Meat CURWOOD, INC. (US) 2012-04-26 US disclosed
US-8110259-B2 Packaging articles, films and methods that promote or preserve the desirable color of meat CURWOOD, INC. (US) 2012-02-07 US disclosed
US-20120015925-A1 NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2012-01-19 US disclosed
EP-1857269-B1 Packaging articles, films and methods that promote or preserve the desirable color of meat CURWOOD INC (US) 2011-09-21 EP disclosed
US-7973030-B2 Benzothiazepine and benzothiepine compounds ASAHI KASEI PHARMA CORPORATION (JP) 2011-07-05 US disclosed
US-7803792-B2 Quaternary ammonium compounds ASAHI KASEI PHARMA CORPORATION (JP) 2010-09-28 US disclosed
EP-0909296-B2 MODIFIED CARBON PRODUCTS AND AMPHIPHILIC IONS CONTAINING COMPOSITIONS CABOT CORP (US) 2010-05-19 EP disclosed
US-7709635-B2 Boronium-ion-based ionic liquids and methods of use thereof UNIVERSITY OF SOUTH ALABAMA (US) 2010-05-04 US disclosed
US-20090318510-A1 TOPICAL DRUG DELIVERY SYSTEM GLYCOBIOSCIENCES, INC. (CA) 2009-12-24 US disclosed
EP-2095942-A1 Method that Promotes or Preserves the Desirable Color of Meat Curwood, Inc. (US) 2009-09-02 EP disclosed
WO-2008083034-A1 TRANSDERMAL VITAMIN B12 DELIVERY PATCH NEXAGEN USA, LLC (US) 2008-07-10 WO disclosed
US-20080160070-A1 TRANSDERMAL VITAMIN B12 DELIVERY PATCH NEXAGEN USA LLC (US) 2008-07-03 US disclosed
EP-1363886-B1 PROCESS AND CATALYST FOR THE PREPARATION OF ACETYLPYRIDINES LONZA AG (CH) 2008-06-04 EP disclosed
EP-1905584-A2 Packaging Inserts with Myoglobiin Blooming Agents, Packages and Methods of Packaging Curwood, Inc. (US) 2008-04-02 EP disclosed
EP-1892093-A2 Webs with synergists that promote or preserve the desirable color of meat Curwood, Inc. (US) 2008-02-27 EP disclosed
US-7312208-B2 Quaternary ammonium compounds ASAHI KASEI PHARMA CORPORATION (JP) 2007-12-25 US disclosed
EP-1866318-A2 THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. (US) 2007-12-19 EP disclosed
EP-1857269-A1 Packaging articles, films and methods that promote or preserve the desirable color of meat Curwood, Inc. (US) 2007-11-21 EP disclosed
EP-1742909-A4 ANIONIC-SWEETENER-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF UNIV SOUTH ALABAMA (US) 2007-10-17 EP disclosed
US-20070237957-A1 Composite plated film, a manufacturing method thereof, laminated films, films for metals used in the dark, a method of preventing corrosion of metal in the dark and composite films MEISEI INDUSTRIAL COMPANY LIMITED (JP) 2007-10-11 US disclosed
US-20070203115-A1 Novel quaternary ammonium compounds ASAHI KASEI PHARMA CORPORATION (JP) 2007-08-30 US disclosed
US-20070190041-A1 Novel benzothiazepine and bensothiepine compounds ASHAI KASEI PHARAMA CORPORATION (JP) 2007-08-16 US disclosed
US-20070104901-A1 Method for distributing a myoglobin-containing food product CURWOOD, INC. 2007-05-10 US disclosed
US-20070072096-A1 Negative curable dye-containing composition, color filter, and method of manufacturing the same FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
CN-1301991-C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same STC NARA CO LTD (KR) 2007-02-28 CN disclosed
US-20070014953-A1 Webs with synergists that promote or preserve the desirable color of meat CURWOOD, INC. (US) 2007-01-18 US disclosed
US-20070014947-A1 Packaging inserts with myoglobin blooming agents, packages and methods for packaging CURWOOD, INC. (US) 2007-01-18 US disclosed
EP-1742909-A2 ANIONIC-SWEETENER-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF University Of South Alabama (US) 2007-01-17 EP disclosed
US-20060287521-A1 Boronium-ion-based ionic liquids and methods of use thereof UNIVERSITY OF SOUTH ALABAMA (US) 2006-12-21 US disclosed
WO-2006125175-A2 BORONIUM-ION-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF UNIVERSITY OF SOUTH ALABAMA (US) 2006-11-23 WO disclosed
EP-1633334-B1 TOPICAL ADMINISTRATION OF VASOACTIVE VITAMIN B3 COMPOUNDS FOR PROMOTING SLEEP PROCTER & GAMBLE (US) 2006-11-15 EP disclosed
US-20060246242-A1 Packaging articles, films and methods that promote or preserve the desirable color of meat BEMIS COMPANY, INC. 2006-11-02 US disclosed
US-20060240978-A1 Process and catalyst for the preparation of acetylpyridines LONZA, AG 2006-10-26 US disclosed
WO-2006094292-A2 THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. (US) 2006-09-08 WO disclosed
US-7067673-B2 Process and catalyst for the preparation of acetylpyridines LONZA AG (CH) 2006-06-27 US disclosed
EP-1633334-A2 A METHOD OF PROMOTING SLEEP USING TOPICAL ADMINISTRATION OF VASOACTIVE AGENTS THE PROCTER & GAMBLE COMPANY (US) 2006-03-15 EP disclosed
US-20060039935-A1 Composition of a transdermal delivery system, which modulates inflammation, via insitu systems, thereby promoting repair of injured, damaged or diseased joints, and soft tissue. Antosh, Mr. Stanley (US) 2006-02-23 US disclosed
CN-1726033-A Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds PHARMACIA & UPJOHN CO LLC (US) 2006-01-25 CN disclosed
US-20050194561-A1 Anionic-sweetener-based ionic liquids and methods of use thereof UNIVERSITY OF SOUTH ALABAMA (US) 2005-09-08 US disclosed
WO-2005072376-A2 ANIONIC-SWEETENER-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF UNIVERSITY OF SOUTH ALABAMA (US) 2005-08-11 WO disclosed
CN-1188550-C Method for electrolytic galvanising using electrolytes containing alkane sulphonic acid BASF AG (DE) 2005-02-09 CN disclosed
CN-1571784-A Piperidine derivatives, process for preparing the same, and pharmaceutical composition for treating alzheimer's disease containing the same STC NARA CO LTD (KR) 2005-01-26 CN disclosed
WO-2005002554-A2 A METHOD OF PROMOTING SLEEP USING TOPICAL ADMINISTRATION OF VASOACTIVE AGENTS THE PROCTER & GAMBLE COMPANY (US) 2005-01-13 WO disclosed
US-20040254202-A1 Method of promoting sleep using topical administration of vasoactive agents THE PROCTER & GAMBLE COMPANY 2004-12-16 US disclosed
US-6811673-B2 ZINC, OR ALLOY THEREOF, MATTE FINISHING; AUTOMOBILE PROTECTIVE COATING BASF AKTIENGESELLSCHAFT (DE) 2004-11-02 US disclosed
US-20040073040-A1 Process and catalyst for the preparation of acetylpyridines LONZA AG (CH) 2004-04-15 US disclosed
EP-1363886-A1 PROCESS AND CATALYST FOR THE PREPARATION OF ACETYLPYRIDINES LONZA AG (CH) 2003-11-26 EP disclosed
CN-1446272-A Method for electrolytic galvanising using electrolytes containing alkane sulphonic acid BASF AG (DE) 2003-10-01 CN disclosed
US-20030141195-A1 Method for electrolytic galvanising using electrolytes containing alkane sulphonic acid BASF AKTIENGESELLSCHAFT (DE) 2003-07-31 US disclosed
WO-2002066433-A1 PROCESS AND CATALYST FOR THE PREPARATION OF ACETYLPYRIDINES LONZA AG (CH) 2002-08-29 WO disclosed
EP-0909296-B1 MODIFIED CARBON PRODUCTS AND AMPHIPHILIC IONS CONTAINING COMPOSITIONS CABOT CORP (US) 2001-10-17 EP disclosed
WO-2001019185-A2 METHODS FOR CONTROLLING A PEST POPULATION SUMMUS GROUP, LTD. (US) 2001-03-22 WO disclosed
US-5939568-A Accelerated catalysis of olefinic epoxidations THE SCRIPPS RESEARCH INSTITUTE (US) 1999-08-17 US disclosed
EP-0909296-A1 MODIFIED CARBON PRODUCTS AND AMPHIPHILIC IONS CONTAINING COMPOSITIONS CABOT CORPORATION (US) 1999-04-21 EP disclosed
WO-1998033786-A9 ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS 1998-12-30 WO disclosed
WO-1998033786-A1 ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 1998-08-06 WO disclosed
WO-1997047691-A1 MODIFIED CARBON PRODUCTS AND AMPHIPHILIC IONS CONTAINING COMPOSITIONS CABOT CORPORATION (US) 1997-12-18 WO disclosed
US-5698016-A INKS, COATINGS CABOT CORPORATION (US) 1997-12-16 US disclosed
US-5240945-A Applying topically lower alkyl nicotinate WARSHAW THELMA G (US) 1993-08-31 US disclosed
WO-1993015713-A2 METHOD AND COMPOSITIONS FOR TREATING ACNE WARSHAW THELMA G (US) 1993-08-19 WO disclosed
EP-0267794-B1 PROCESS FOR PREPARING POLYOLEFINS Nippon Petrochemicals Co., Ltd. (JP) 1993-05-05 EP disclosed
US-5157036-A Composition for inducing and stimulating hair growth and retarding its loss, based on nicotinic esters and pyrimidine derivatives L'OREAL (FR) 1992-10-20 US disclosed
EP-0489581-A2 Cosmetic composition UNILEVER PLC (GB) 1992-06-10 EP disclosed
US-4968685-A ALOPECIA L'OREAL (FR) 1990-11-06 US disclosed
EP-0267794-A2 Process for preparing polyolefins Nippon Petrochemicals Co., Ltd. (JP) 1988-05-18 EP disclosed
CN-85104268-A 1,4-dihydro-2, the preparation of 6-dimethyl-3-(carbalkoxy or alkoxyl group carbalkoxy)-4-(substituted-phenyl)-pyridine-5-carboxylic acid esters 1986-12-03 CN disclosed
US-4525555-A TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS NIPPON OIL COMPANY, LIMITED (JP) 1985-06-25 US disclosed
JP-S5813607-A PREPARATION OF OLEFIN COPOLYMER RUBBER NIPPON II P RUBBER KK 1983-01-26 JP disclosed
EP-0037634-A1 Zinc plating baths and additives therefor Albright & Wilson Limited (GB) 1981-10-14 EP disclosed
US-4207150-A NON-CYANIDE ZINC ELECTROPLATING BATH CONTAINING QUATERNARY BUTYL NICOTINATE SULFATE OR SULFONATE AS BRIGHTENER AND LEVELING AGENT OXY METAL INDUSTRIES CORPORATION (US) 1980-06-10 US disclosed
US-4207150-A NON-CYANIDE ZINC ELECTROPLATING BATH CONTAINING QUATERNARY BUTYL NICOTINATE SULFATE OR SULFONATE AS BRIGHTENER AND LEVELING AGENT OXY METAL INDUSTRIES CORPORATION (US) 1980-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (27 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060240978-A1 Process and catalyst for the preparation of acetylpyridines CHRM1, APEH, CHRM2 L3MBTL1 4676/4885LMNA 1531/4885KMT2A 2150/4885
US-20120264709-A1 NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS TYMP, PNP, DUT L3MBTL1 3752/4885LMNA 1746/4885KMT2A 2964/4885
US-10646569-B2 High concentration protein formulations with reduced viscosity ALB, TTR, MAX L3MBTL1 2534/4885LMNA 2955/4885KMT2A 4024/4885
US-20200087338-A1 NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS TYMP, PNP, DUT L3MBTL1 3752/4885LMNA 1746/4885KMT2A 2964/4885
US-20190263777-A1 SYNTHESIS AND RESOLUTION OF NICOTINE TMT1A, TST, NAPRT L3MBTL1 1104/4885LMNA 2098/4885KMT2A 386/4885
US-20040073040-A1 Process and catalyst for the preparation of acetylpyridines TCP1, CHRM1, ANO1 L3MBTL1 4679/4885LMNA 1278/4885KMT2A 2250/4885
US-20200254094-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY ALB, TTR, MAX L3MBTL1 2534/4885LMNA 2955/4885KMT2A 4024/4885
US-20180030028-A1 SYNTHESIS AND RESOLUTION OF NICOTINE TMT1A, TST, NAPRT L3MBTL1 1104/4885LMNA 2098/4885KMT2A 386/4885
US-10329271-B2 Synthesis and resolution of nicotine TMT1A, TST, NAPRT L3MBTL1 1104/4885LMNA 2098/4885KMT2A 386/4885
US-11738082-B2 High concentration protein formulations with reduced viscosity ALB, TTR, MAX L3MBTL1 2534/4885LMNA 2955/4885KMT2A 4024/4885
US-20120270900-A1 NOVEL METHOD OF TREATMENT NAPRT, NAMPT, NNT L3MBTL1 2404/4885LMNA 3049/4885KMT2A 924/4885
US-20070203115-A1 Novel quaternary ammonium compounds SLC10A2, SLC10A1, ABCB11 L3MBTL1 4652/4885LMNA 4674/4885KMT2A 3183/4885
US-20240115702-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY ALB, TTR, MAX L3MBTL1 2534/4885LMNA 2955/4885KMT2A 4024/4885
US-10759776-B2 Synthesis and resolution of nicotine TMT1A, TST, NAPRT L3MBTL1 1104/4885LMNA 2098/4885KMT2A 386/4885
US-20180333493-A1 HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY ALB, TTR, MAX L3MBTL1 2534/4885LMNA 2955/4885KMT2A 4024/4885
US-12473310-B2 Vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound VDR, CYP24A1, CYP2R1 L3MBTL1 4489/4885LMNA 4275/4885KMT2A 4654/4885
US-20120291737-A1 LUBRICANT COMPOSITIONS CONTAINING A HETEROAROMATIC COMPOUND HRH3, TRIB1, HRH4 L3MBTL1 2423/4885LMNA 2767/4885KMT2A 1456/4885
US-11926644-B2 Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives NQO1, NME4, NQO2 L3MBTL1 3044/4885LMNA 1331/4885KMT2A 1583/4885
US-20130123505-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE HCAR2, NAAA, FAAH2 L3MBTL1 4136/4885LMNA 3379/4885KMT2A 390/4885
US-20150337007-A1 PROCESS FOR THE PREPARATION OF UNSATURATED TRIFLUOROMETHANESULFONATE STEROID DERIVATIVES NR5A1, AKR1C4, AR L3MBTL1 3923/4885LMNA 1680/4885KMT2A 2087/4885
US-20230263718-A1 COMPOSITION FOR TREATING HAIR OR FIBERS, COMPRISING ALKYL KETENE COMPOUND KRT18, KAT5, KCNK5 L3MBTL1 4561/4885LMNA 2295/4885KMT2A 213/4885
US-20160326134-A1 SYNTHESIS AND RESOLUTION OF NICOTINE TMT1A, TST, NAPRT L3MBTL1 1104/4885LMNA 2098/4885KMT2A 386/4885
US-20120015925-A1 NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS SLC10A1, SREBF1, SPTLC1 L3MBTL1 981/4885LMNA 1909/4885KMT2A 404/4885
US-20060287521-A1 Boronium-ion-based ionic liquids and methods of use thereof IPO4, SLC9B2, INF2 L3MBTL1 432/4885LMNA 746/4885KMT2A 1289/4885
US-20050194561-A1 Anionic-sweetener-based ionic liquids and methods of use thereof NUDT1, TAS1R3, TAS2R30 L3MBTL1 3490/4885LMNA 4449/4885KMT2A 3498/4885
US-20240116959-A1 VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND VDR, CYP24A1, CYP2R1 L3MBTL1 4489/4885LMNA 4275/4885KMT2A 4654/4885
US-20070190041-A1 Novel benzothiazepine and bensothiepine compounds SLC10A1, GOT1, CES1 L3MBTL1 427/4885LMNA 2785/4885KMT2A 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.